Hjem
August Bakkes bilde

August Bakke

Professor emeritus
  • E-postAugust.Bakke@uib.no
  • Telefon+47 55 97 27 56
  • Besøksadresse
    Haukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst
    5009 Bergen
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • Vis forfatter(e) (2016). Preventing Complications - The Preflight Checklist. European Urology Focus. 60-62.
  • Vis forfatter(e) (2016). Development of a disease-specific health-related quality of life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in renal cell carcinoma patients. Acta Oncologica. 349-356.
  • Vis forfatter(e) (2015). Health-related quality of life, personality and choice of coping are related in renal cell carcinoma patients. Scandinavian Journal of Urology. 282-289.
  • Vis forfatter(e) (2010). Voiding disorders among children and adolescents: surveillance after voiding school treatment. International Journal of Urological Nursing. 22-32.
  • Vis forfatter(e) (2010). Pad per day usage, urinary incontinence and urinary tract infections in nursing home residents. Age and Ageing. 549-554.
  • Vis forfatter(e) (2008). Residual urine as a risk factor for lower urinary tract infection: A 1-year follow-up study in nursing homes. Journal of The American Geriatrics Society. 871-874.
  • Vis forfatter(e) (2008). Dynamic contrast enhanced magnetic resonance imaging of bladder cancer and implications for biological image-adapted radiotherapy. Acta Oncologica. 1257-1264.
  • Vis forfatter(e) (2007). Renal cell carcinoma: A clinicopathological follow-up study after radical nephrectomy. Scandinavian Journal of Urology and Nephrology. 191-197.
  • Vis forfatter(e) (2007). Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. Multiple Sclerosis. 106-112.
  • Vis forfatter(e) (2007). Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. Multiple Sclerosis. 106-112.
  • Vis forfatter(e) (2006). Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study. BJU International. 698-702.
  • Vis forfatter(e) (2006). A concomitant tumour boost in bladder irradiation: Patient suitability and the potential of intensity-modulated radiotherapy. Radiotherapy and Oncology. 98-105.
  • Vis forfatter(e) (2005). Gene expression profiles in prostate cancer: Association with patient subgroups and tumour differentiation. International Journal of Oncology. 329-336.
  • Vis forfatter(e) (2004). The Potentially Curable Prostate Cancer Patient and the Pathways Leading to Diagnosis and Treatment. Scandinavian Journal of Urology and Nephrology. 15-18.
  • Vis forfatter(e) (2004). Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia. International Journal of Radiation Oncology, Biology, Physics. 476-482.
  • Vis forfatter(e) (2001). Vannlatingsproblemer og urinveiskomplikasjoner hos ungdom og voksne med myelomeningocele. Tidsskrift for Den norske legeforening. 1211-5.
  • Vis forfatter(e) (2001). Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Multiple Sclerosis. 231-235.
  • Vis forfatter(e) (2001). Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Multiple Sclerosis. 231-235.
  • Vis forfatter(e) (2001). Reduced quality of life among MS patients with sexual disturbance and bladder dysfunction. Multiple Sclerosis. 231-235.
  • Vis forfatter(e) (2001). Reduced quality of life among MS patients with sexual disturbance and bladder dysfunction. Multiple Sclerosis. 231-235.
  • Vis forfatter(e) (2001). Reconstructive urology in the nordic countries - a hospital questionnaire survey. Scandinavian Journal of Urology and Nephrology. 186-9.
  • Vis forfatter(e) (2001). Oppfølgning av urinveisproblemer hos voksne med myelomeningocele. Tidsskrift for Den norske legeforening. 1247-51.
  • Vis forfatter(e) (1998). Psychological predictors of symptoms of urinary tract infection and bacteriuria in patients treated with clean intermittent catheterization. European Urology. 30-36.
  • Vis forfatter(e) (1997). Utredning og oppfølgning ved BPH. Nytt om legemidler forts. av: Nytt fra Statens legemiddelkontroll. 19-20.
  • Vis forfatter(e) (1997). Physical predictors of infection in patients treated with clean intermittent catheterization: a prospective 7-year study. British Journal of Urology. 85-90.
  • Vis forfatter(e) (1997). Physical predictors of infection in patients treated with clean intermittent catheterization: a prospective 7-year study. British Journal of Urology. 85-90.
  • Vis forfatter(e) (1997). Perforation of continent urinary reservoirs - Scandinavian experience. Scandinavian Journal of Urology and Nephrology. 529-532.
  • Vis forfatter(e) (1997). Inhibition of mitogen-induced lymphoproliferation by soluble annexin II in sera from patients with renal carcinoma. APMIS - Journal of Pathologiy, Microbiology and Immunology. 699-704.
  • Vis forfatter(e) (1996). Urinveisinfeksjon hos pasienter behandlet med selvkateterisering. En prevalensundersøkelse av pasienter på langtids ren intermitterende kateterisering. Tidsskrift for Den norske legeforening. 2552-2555.
  • Vis forfatter(e) (1996). Urinveisinfeksjon hos pasienter behandlet med selvkateterisering. En prevalens undersøkelse av pasienter på langtids ren intermitterende kateterisering. Tidsskrift for Den norske legeforening. 2552-2555.
  • Vis forfatter(e) (1996). Tamsulosin, the First Prostate-Selective _a1A-Adrenoceptor Antagonist. Analysis of a multinational, multicentre, open-label study assessing the long-term efficacy and safety in patients with benign prostatic Obstruction (Symptomatic BPH). European Urology. 145-154.
  • Vis forfatter(e) (1996). Tamsulosin, the First Prostate-Selective _a1A-Adrenoceptor Antagonist. A Meta-analysis of two randomized placebo-controlled, multicentre studies in patients with benign prostatic obstruction (Symptomatic BPH). European Urology. 155-167.
  • Vis forfatter(e) (1996). Bladder, bowel and sexual dysfunction in patients with multiple sclerosis - a cohort study. Scandinavian Journal of Urology and Nephrology. 61-66.
  • Vis forfatter(e) (1996). Bladder, bowel and sexual dysfunction in patients with multiple sclerosis - a cohort study. Scandinavian Journal of Urology and Nephrology. 61-66.
  • Vis forfatter(e) (1995). Ureteroscopy in pregnancy. Journal of Urology. 1660-1663.
  • Vis forfatter(e) (1994). Psychosocial adjustment to illness scale (PAIS-SR) in a Norwegian material of patients with functional dyspepsia, duodenal ulcer, and urinary bladder dysfunction. Scandinavian Journal of Gastroenterology. 611-617.
  • Vis forfatter(e) (1994). Normalisering av blæretømmingen hos pasienter på ren intermitterende katerisering. Nordisk Medicin. 56-57.
  • Vis forfatter(e) (1994). Clean intermittent catheterization in lower urinary tract dysfunction - an overview. Scandinavian Journal of Urology and Nephrology. 55-60.
  • Vis forfatter(e) (1993). Social functioning and general well-being in patients treated with clean intermittent catheterization. Journal of Psychosomatic Research. 371-380.
  • Vis forfatter(e) (1993). Risk factors for bacteriuria and clinical urinary tract infection in patients treated with clean intermittent catheterization. Journal of Urology. 527-531.
  • Vis forfatter(e) (1993). Risk factors for bacteriuria and clinical urinary tract infection in patients treated with clean intermittent catheterization. Journal of Urology. 527-531.
  • Vis forfatter(e) (1993). Risk factors for bacteriuria and clinical urinary tract infection in patients treated with clean intermittent catheterization. Journal of Urology. 527-531.
  • Vis forfatter(e) (1993). Risk factors for bacteriuria and clinical urinary tract infection in patients treated with clean intermittent catherisation. Journal of Urology. 527-531.
  • Vis forfatter(e) (1993). Physical complications in patients treated with clean intermittent catheterization. Scandinavian Journal of Urology and Nephrology. 55-61.
  • Vis forfatter(e) (1993). Physical complications in patients treated with clean intermittent catheterization. Scandinavian Journal of Urology and Nephrology. 55-61.
  • Vis forfatter(e) (1993). Physical complications in patients treated with clean intermittent catheterization. Scandinavian Journal of Urology and Nephrology. 55-61.
  • Vis forfatter(e) (1993). Physical complications in patients treated with clean intermittent catheterisation. Scandinavian Journal of Urology and Nephrology. 55-61.
  • Vis forfatter(e) (1993). Clean intermittent catheterization. Physical and psychological complications. J Urol Nephrol. Suppl. 1-69.
  • Vis forfatter(e) (1993). Clean intermittent catheterization-performing abilities, aversive experiences and distress. Paraplegia. 288-297.
  • Vis forfatter(e) (1993). Clean intermittent catheterization - performing abilities, aversive experiences and distress. International Medical Society of Paraplegia. 288-297.
  • Vis forfatter(e) (1993). Clean intermittent catheterisation - performing abilities, aversive experiences and distress. Paraplegia. 288-297.
  • Vis forfatter(e) (1992). What is the requirement of clean intermittent catheterization? - An epidemiologic study. Neurourology and Urodynamics. 414-415.
  • Vis forfatter(e) (1992). Physical complications and their risk factors in patients treated with clean intermittent catheterization. Neurourology and Urodynamics. 412-413.
  • Vis forfatter(e) (1992). Incidence of improvement of bladder emptying in 1702 patients on clean intermittent catheterization. Neurourology and Urodynamics. 411-412.
  • Vis forfatter(e) (1992). Clinical background of patients treated with cleanintermittent catherization in Norway. Scandinavian Journal of Urology and Nephrology. 211-217.
  • Vis forfatter(e) (1992). Clinical background of patients treated with clean intermittent catheterization in Norway. Scandinavian Journal of Urology and Nephrology. 211-217.
  • Vis forfatter(e) (1992). Clinical background of patients treated with clean intermittent catherization in Norway. Scandinavian Journal of Urology and Nephrology. 211-217.
  • Vis forfatter(e) (1991). Urinary tract infection in patients treated with clean intermittent catheterization - predictive variables. Scandinavian Journal of Urology and Nephrology. 76-77.
  • Vis forfatter(e) (1991). Quality of life and discomfort in patients with clean intermittent catheterization. Neurourology and Urodynamics. 305-306.
  • Vis forfatter(e) (1991). Clinical background of patients treated with clean intermittent catheterization in Norway. Scandinavian Journal of Urology and Nephrology.
  • Vis forfatter(e) (1991). Bacteriuria in patients treated with clean intermittent catheterization. Scandinavian Journal of Infectious Diseases. 577-582.
  • Vis forfatter(e) (1991). Bacteriuria in patients treated with clean intermittent catheterization. Scandinavian Journal of Infectious Diseases. 577-582.
  • Vis forfatter(e) (1991). Bacteriuria in patients treated with clean intermittent catheterization. Scandinavian Journal of Infectious Diseases. 577-582.
  • Vis forfatter(e) (1985). Screening for hematuria, glucosuria and proteinuria in people aged 55-64. Scandinavian Journal of Primary Health Care. 31-34.
Vitenskapelig foredrag
  • Vis forfatter(e) (2005). A concomitant tumour boost in bladder irradiation: Patient suitability and the potensial of intensity-modulated radiotherapy.
  • Vis forfatter(e) (2004). Gene expression profiling in prostate cancer refined by pairwise comparisons of cDNA microarrays from benign and malignant tissue.
  • Vis forfatter(e) (2003). Global analysis of gene expression and regulatory patterns in urogenital tumours using DNA microarrays.
  • Vis forfatter(e) (2003). Global analysis of gene expression and regulatory patterns in cancer.
  • Vis forfatter(e) (2003). Gene expression profiling in prostate cancer: Cluster analysis and association with tumor differentiation.
  • Vis forfatter(e) (2003). Gene expression profiling in prostate cancer.
  • Vis forfatter(e) (2003). DNA microarray studies of human cancer - pitfalls and outlook.
  • Vis forfatter(e) (2003). Comparison of DNA microarray and real time quantitative PCR for quantitation of gene expression of selected genes in prostate cancer.
  • Vis forfatter(e) (2002). Genital selvmutilering (GSM) - ren skjær galskap eller .. ?
  • Vis forfatter(e) (2000). Survival after radical nephrectomy for renal cell carcinoma in 103 patients.
Leder
  • Vis forfatter(e) (2020). Når barn ikke får kontroll med vannlatingen. Tidsskrift for Den norske legeforening. 1-2.
Mastergradsoppgave
  • Vis forfatter(e) (2008). Uroterapi til barn og unge -hvor står vi ? -hvor går vi?
Doktorgradsavhandling
  • Vis forfatter(e) (2015). Time relations of biological markers in urothelial carcinomas.
  • Vis forfatter(e) (2015). Health-related Quality of Life, Distress and Psychosocial Factors in Head and Neck and Renal Cancer Patients. Quality of Life in HNSCC and RCC patients.
  • Vis forfatter(e) (1992). Clean intermittent catheterization - physical and psychological complications.
Vitenskapelig Kapittel/Artikkel/Konferanseartikkel
  • Vis forfatter(e) (1997). Treatment of BPH - the primary evaluation and follow-up procedures.
  • Vis forfatter(e) (1991). Urinveisforstyrrelser. 15 sider.
Sammendrag/abstract
  • Vis forfatter(e) (2009). Residual Urine as a Risk Factor for Lower Urinary Tract Infection: A 1-Year Follow-Up Study in Nursing Homes. Journal of Urology. 1139-1139.
Poster
  • Vis forfatter(e) (2003). Gene expression profiling in prostate cancer refined by pairwise comparisons of cDNA microarrays from benign and malignant tissue.

Se fullstendig oversikt over publikasjoner i CRIStin.